CN Stock MarketDetailed Quotes

300347 Hangzhou Tigermed Consulting

Watchlist
  • 60.05
  • -2.34-3.75%
Market Closed Nov 18 15:00 CST
51.94BMarket Cap54.20P/E (TTM)

Hangzhou Tigermed Consulting Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hangzhou Tigermed Consulting FY2024 9-Month Earnings Date

Currency：CNYOct 29, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
5.07B
--
-10.32%
EPS
--
0.94
--
-56.68%
Analyst Rating
Strong Buy

Nov 18, 2024

Hangzhou Tigermed Consulting Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.901B--
--2024/Q4-- / 1.986B--
--2024/Q31.709B / 2.053B--
--2024/Q21.698B / 2.066B--
--2024/Q11.660B / 2.216B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.901B--
--2024/Q4-- / 1.986B--
--2024/Q31.709B / 2.053B--
--2024/Q21.698B / 2.066B--
--2024/Q11.660B / 2.216B--

Unlock Free Earnings Estimates

Hangzhou Tigermed Consulting Earnings Reports

  • Tiger Pharmaceuticals: Report for the third quarter of 2024

    Oct 30 00:00

  • Tiger Pharmaceuticals: 2024 Semi-Annual Report Summary

    Aug 29 00:00

  • Tiger Pharmaceuticals: Semi-Annual Report 2024

    Aug 29 00:00

  • Hangzhou Tigermed Consulting: 2024 First Quarter Report

    Apr 26 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 18, 2024

    Strong Buy

    • Strong Buy

      78.26%

    • Buy

      21.74%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data